Physio-Control receives US clearance for Lifepak 15 monitor/defibrillator

8 April 2009

Physio-Control, Inc., a wholly owned subsidiary of Medtronic, (NYSE: MDT) has received clearance from the US FDA to market the LIFEPAK 15 monitor/defibrillator within the United States.

“With the LIFEPAK 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so they can focus on the most important task at hand — saving lives,” said Brian Webster, president of Physio-Control. “This industry was built on the innovations delivered by Physio-Control and the LIFEPAK 15 monitor continues to define the new standard for emergency care products.”

With nearly 700,000 LIFEPAK defibrillators distributed worldwide, the company is one of the world’s leading providers of external defibrillation and monitoring technology for the treatment of sudden cardiac arrest and other cardio-respiratory emergencies.

Physio-Control entered into a consent decree with the FDA in May, 2008. The decree currently places restrictions on the type and amount of products which may be shipped until improvements to the company’s quality system have been confirmed. In the interim, Physio is able to ship a limited selection of product to meet customer needs.

Bookmark this page

To top